Get Resources & Stay in Touch with HP+ Indonesia
Use the form below to subscribe to updates on HP+ Indonesia activities (first option) or simply receive a one-time email with links to the resources you select.
HIV Costing and Financing
The government of Indonesia is committed to combatting the country’s HIV epidemic by strengthening policy frameworks and adopting fast-track targets geared at accelerating progress toward achieving epidemic control. In the context of these programmatic changes and anticipated decreasing external financing, understanding total cost is essential to plan and advocate for HIV funding. In collaboration with Indonesia’s Sub-Directorate of HIV/AIDS in the Ministry of Health, HP+ has conducted subnational HIV costing and impact analyses found in this collection of country program products.
JKN Comprehensive Assessment
Indonesia’s national health insurance scheme Jaminan Kesehatan Nasional, or JKN, is one of the most ambitious single-payer programs in the world. Launched in January 2014, JKN has made notable progress in increasing enrollment in just a few short years. Some questions addressed by this collection of HP+ publications are:
- How can the government improve the predictability of its outlays to the scheme?
- Has healthcare utilization improved since JKN and are there variations across socioeconomic status or geography?
- What affects healthcare utilization, other than insurance coverage?
- Is JKN leading to more appropriate use of primary versus secondary/tertiary care?
- Who benefits from government expenditure on JKN?
- How has JKN hospital expenditure been distributed across island and socioeconomic groups?
As JKN continues to scale-up toward universal coverage, critical policy decisions are required to increase revenue, rationalize healthcare expenditure, and project any future deficits to ensure the scheme is managed sustainably.
Private Sector & Civil Society Landscape
Indonesia’s middle-income population is on the rise, its democracy continues to become more open, and its economy continues to grow. Despite these positive developments, it has yet to take a similar lead on many health issues, especially in maternal and newborn health (MNH). With the roll-out in January 2014 of national health insurance scheme Jaminan Kesehatan Nasional, or JKN, there is both urgency and opportunity to leverage Indonesia’s robust private sector, civil society, media, and academic institutions for their expertise and resources to improve MNH outcomes. This collection of HP+ Indonesia products explore some of the opportunities for collaboration between civil society and private sector to foster improvements for the health sector in Indonesia.